Whitehawk Therapeutics Stock (NASDAQ: WHWK)

Whitehawk Therapeutics

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics Inc

Earnings

Press Releases

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

WHWK

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Atossa Therapeutics

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics

Avalo Therapeutics

Biomea Fusion

Climb Bio

Caribou Biosciences

Fate Therapeutics

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

HilleVax

Macrogenics

OncoCyte

Renovaro

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Senti Biosciences

Vigil Neuroscience

Vor Biopharma

Exicure

Exagen

Zura Bio Limited - Class A Ordinary shares

Comments

Whitehawk Therapeutics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga